We are live on ! Find out more
TI

tru Independence Portfolio holdings

AUM $202M
1-Year Est. Return 15.81%
This Fund
S&P 500
This Quarter Est. Return
-20.27%
1 Year Est. Return
+15.81%
3 Year Est. Return
+42.5%
5 Year Est. Return
+46.34%
10 Year Est. Return
–
AUM
$613K
AUM Growth
-$694M
Cap. Flow
-$229M
Cap. Flow %
-37,377.98%
Top 10 Hldgs %
43.1%
Holding
965
New
6
Increased
47
Reduced
75
Closed
214

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$23.5M
2
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$22.6M
3
IUSV icon
iShares Core S&P US Value ETF
IUSV
+$18.8M
4
SCHF icon
Schwab International Equity ETF
SCHF
+$14.3M
5
FBT icon
First Trust NYSE Arca Biotechnology Index Fund
FBT
+$14M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$49.3M
2
DTE icon
DTE Energy
DTE
+$17M
3
SBUX icon
Starbucks
SBUX
+$9.35M
4
BHF icon
Brighthouse Financial
BHF
+$8.94M
5
BNY
Bank of New York Mellon
BNY
+$8.69M

Sector Composition

Rank Sector Weight
1 Technology 10.3%
2 Healthcare 9.04%
3 Financials 7.22%
4 Consumer Staples 6.76%
5 Consumer Discretionary 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HUM icon
626
Humana
HUM
$46.7B
$2 ﹤0.01%
5
– –
ICUI icon
627
ICU Medical
ICUI
$4.14B
$2 ﹤0.01%
9
– –
IONS icon
628
Ionis Pharmaceuticals
IONS
$9.14B
$2 ﹤0.01%
36
– –
IT icon
629
Gartner
IT
$10.4B
$2 ﹤0.01%
20
– –
KWR icon
630
Quaker Houghton
KWR
$2.67B
$2 ﹤0.01%
12
– –
LYG icon
631
Lloyds Banking Group
LYG
$87.2B
$2 ﹤0.01%
1,251
– –
MRVL icon
632
Marvell Technology
MRVL
$157B
$2 ﹤0.01%
100
– –
MTB icon
633
M&T Bank
MTB
$36.6B
$2 ﹤0.01%
19
– –
NBIX icon
634
Neurocrine Biosciences
NBIX
$18.4B
$2 ﹤0.01%
18
– –
NOTV
635
DELISTED
Inotiv
NOTV
$2 ﹤0.01%
500
– –
NTNX icon
636
Nutanix
NTNX
$16B
$2 ﹤0.01%
100
– –
PNC icon
637
PNC Financial Services
PNC
$100B
$2 ﹤0.01%
24
– –
RBC icon
638
RBC Bearings
RBC
$18.2B
$2 ﹤0.01%
17
– –
REFR icon
639
Research Frontiers
REFR
$15.2M
$2 ﹤0.01%
1,000
– –
RELX icon
640
RELX
RELX
$66B
$2 ﹤0.01%
99
– –
RPD icon
641
Rapid7
RPD
$642M
$2 ﹤0.01%
35
– –
RPM icon
642
RPM International
RPM
$14.3B
$2 ﹤0.01%
42
– –
SAN icon
643
Banco Santander
SAN
$200B
$2 ﹤0.01%
994
– –
SUI icon
644
Sun Communities
SUI
$15.3B
$2 ﹤0.01%
19
– –
TGTX icon
645
TG Therapeutics
TGTX
$8.4B
$2 ﹤0.01%
200
– –
TTC icon
646
Toro Company
TTC
$9.08B
$2 ﹤0.01%
37
– –
TYL icon
647
Tyler Technologies
TYL
$13.7B
$2 ﹤0.01%
7
– –
WAL icon
648
Western Alliance Bancorporation
WAL
$9.13B
$2 ﹤0.01%
50
– –
WIT icon
649
Wipro
WIT
$19B
$2 ﹤0.01%
1,106
– –
QVCGA
650
DELISTED
QVC Group Inc Series A
QVCGA
$2 ﹤0.01%
5
– –
24 25
26
27 28

Similar funds

BFA
Brendel Financial Advisors Hanover, New Hampshire $202M AUM 37.99% 1-Year Est. Return
PCMK
Paragon Capital Management (Kansas) Overland Park, Kansas $202M AUM 26.44% 1-Year Est. Return
AFWM
Arta Finance Wealth Management Mountain View, California $202M AUM
PCM
Pointe Capital Management Grosse Pointe Farms, Michigan $202M AUM 17.2% 1-Year Est. Return
IFU
iSAM Funds (UK) London, United Kingdom $203M AUM 18.34% 1-Year Est. Return
MFG
Marmo Financial Group Johnson City, Tennessee $202M AUM 13.32% 1-Year Est. Return
GW
Griffith & Werner Canton, Georgia $202M AUM
RA
Riverstone Advisors New Braunfels, Texas $203M AUM 27.33% 1-Year Est. Return

tru Independence's Q1 2020 Portfolio in Review

As of Q1 2020, tru Independence held 965 positions worth $613K, down 100% from $695M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

tru Independence withdrew a net $229M in Q1 2020, closing 214 positions and reducing 75 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $49.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 10% a quarter earlier, followed by Healthcare and Financials.

Against the trend, tru Independence opened a new position in Norbord Inc. worth $3.02K.

  • tru Independence's largest Q1 2020 buy was Norbord Inc.: 254,795 shares worth $3.02K.
  • tru Independence added most to State Street SPDR S&P Biotech ETF in Q1 2020, an estimated $23.5M increase.
  • tru Independence's biggest Q1 2020 reduction was DTE Energy, cutting an estimated $17M.
  • tru Independence fully exited Bristol-Myers Squibb in Q1 2020, selling an estimated $49.3M.
  • tru Independence's ten largest holdings make up 43% of its $613K portfolio in Q1 2020.
  • tru Independence opened 6 new positions and closed 214 in Q1 2020.
  • tru Independence's portfolio value fell 100% quarter-over-quarter to $613K.

Based on tru Independence's 13F filing for Q1 2020, filed 19 May 2020.